Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pathology · Breast Cancer

What Does LVI Mean in Upper-Outer Quadrant Breast Cancer?

At a Glance

On a breast cancer pathology report, lymphovascular invasion (LVI) means cancer cells were seen inside small lymphatic channels or blood vessels near the tumor. It may be associated with higher recurrence risk, but it does not prove spread, mean Stage IV disease, or determine treatment by itself.

When you see “lymphovascular invasion” (often abbreviated as LVI) on your breast cancer pathology report, it means the pathologist saw cancer cells inside the tiny lymphatic channels or blood vessels in or immediately surrounding your breast tumor [1][2]. The lymphatic and circulatory systems transport fluid and blood through the body. LVI means cancer cells have entered these vessels, but finding them there does not prove they have traveled elsewhere or established a tumor in another organ [3].

It is completely understandable to feel frightened by this finding. However, it is a routine part of breast cancer pathology reporting, and LVI by itself does not mean the cancer is Stage IV, nor does it automatically change your overall cancer stage [4][5].

LVI vs. Positive Lymph Nodes

It is very common to confuse lymphovascular invasion with a “positive lymph node” or distant metastasis, but they are medically distinct concepts [4][5]:

Finding What it means What it does NOT mean
Lymphovascular Invasion (LVI) Cancer cells are seen inside the tiny vessels near the original breast tumor [1]. Does not mean cancer has spread to lymph nodes or other organs. Does not automatically change your stage [4].
Positive Lymph Node (Nodal Metastasis) Cancer cells are actually found within a lymph node (even as a very small deposit) [6]. Does not mean cancer has spread to distant organs like the liver or bones [4].
Distant Metastasis Cancer has spread to and established a tumor in a completely different organ [4]. (This is the definition of Stage IV disease.)

Research shows that LVI is more common in patients who have positive lymph nodes, but it is also frequently found in patients whose lymph nodes are completely clear of cancer [5][7].

What LVI Means for Your Risk

LVI is considered an adverse prognostic feature. This means that, when studying large groups of patients, LVI is associated with a somewhat higher risk of the cancer returning to the breast area (locoregional recurrence) or spreading (distant metastasis) [8][9].

However, LVI is an association seen in groups, not a prediction of your personal outcome. There is no single universal risk score, and no personal recurrence percentage can be calculated from LVI alone [6][10]. Your care team will use your complete pathology picture to estimate your risk. Your lymph node status remains a major factor in staging and prognosis, while LVI provides additional clues to help refine that assessment [6].

How LVI Affects Your Treatment Plan

Your care team will not make treatment decisions based on LVI alone [11][12]. LVI by itself does not dictate whether you need chemotherapy, hormone therapy, or targeted treatments. Instead, doctors look at it alongside several other critical factors:

  • Tumor size and grade: How large the tumor is and how aggressive the cells look under a microscope [4][13].
  • Hormone Receptors (ER/PR) and HER2: Specific proteins on the cancer cells that help guide systemic treatments [14][13].
  • Lymph node status: Whether cancer cells were found in the nodes during surgery [7].
  • Surgical Margins: How close the cancer cells were to the edge of the tissue removed.

In practical terms, LVI might be considered in selected borderline cases [15]. For example, if your care team is debating whether to recommend radiation therapy after a mastectomy, LVI might be one of many factors (along with age, tumor size, and margins) weighed to make that decision [15][16]. Even then, the potential benefits of radiation must be carefully balanced against possible harms, such as lymphedema (chronic swelling) or exposure to the heart and lungs.

Pathology reports vary in how they describe LVI. Some reports will simply state “LVI present,” while others might use terms like “focal” (a small amount) or “extensive” (a large amount). Additionally, because routine stains cannot always easily tell blood vessels and lymphatic vessels apart, your report may not specify which type of vessel was involved [17][11]. Your oncologist can help explain exactly how the findings in your specific report fit into your overall individualized treatment plan.

Common questions in this guide

What does lymphovascular invasion mean on a breast cancer pathology report?
Lymphovascular invasion, or LVI, means the pathologist saw breast cancer cells inside small lymphatic channels or blood vessels in or near the tumor. It shows that cells entered nearby vessels, but it does not prove that cancer has reached lymph nodes or another organ.
Does the upper-outer quadrant location change what LVI means?
No. The upper-outer quadrant describes where the breast tumor is located, while LVI describes cancer cells seen inside nearby small lymphatic channels or blood vessels. Your oncology team interprets both findings with the rest of your pathology.
Is LVI the same as having positive lymph nodes?
No. LVI is cancer cells in small vessels near the breast tumor, while a positive lymph node means cancer cells were found inside a lymph node. The two findings can occur together, but one does not prove the other.
Does LVI mean my breast cancer is stage IV?
No. LVI alone does not mean the cancer is stage IV or automatically change its stage. Stage IV means cancer has spread to and established a tumor in a distant organ, and your stage is determined from the complete pathology picture rather than LVI alone.
Does lymphovascular invasion increase the chance that breast cancer will return?
Studies of groups of patients find that LVI is associated with a somewhat higher risk of cancer returning near the breast or spreading to distant sites. This association cannot predict your individual outcome or provide a personal recurrence percentage by itself.
Will LVI change my breast cancer treatment?
LVI usually does not determine chemotherapy, hormone therapy, targeted treatment, or radiation by itself. Doctors consider it with tumor size and grade, hormone receptor and HER2 results, lymph node status, and surgical margins, especially when weighing treatment options in borderline cases.
What do focal or extensive LVI mean on a pathology report?
These terms describe how much LVI was seen: focal means a small amount, while extensive means a larger amount. Routine stains may not always show whether the involved vessels were lymphatic or blood vessels, so your pathologist or oncologist can explain the wording in your report.

Related questions

What Do HER2 2+ or Discordant Results Mean in Breast Cancer? How Are Multifocal, Multicentric Breast Cancers Diagnosed? When Can I Resume Exercise After Breast Cancer Surgery? How Is a Breast or Armpit Lump Evaluated for Breast Cancer? How Is an Axillary-Tail Tumor Staged in Breast Cancer?
Show more
What Do Breast Cancer Stage Labels Mean? TNM & Prognostic What Does No Ink on Tumor Mean for Lumpectomy Margins? When Is Breast MRI Recommended Before Breast Cancer Surgery? How Does Invasive Lobular Differ From Ductal Breast Cancer? Should a Suspicious Armpit Node Be Biopsied First? How Does Radiation Affect Breast Reconstruction Choices? ER-Low Positive Breast Cancer: Is Endocrine Therapy Needed? When Are Oncotype DX and MammaPrint Used in Breast Cancer? Can Oncoplastic Surgery Improve Shape After Lumpectomy? How Do I Choose Lumpectomy vs Mastectomy for Breast Cancer? How Is DCIS Treated Differently From Invasive Breast Cancer? How Is Ki-67 Interpreted in Upper-Outer Breast Cancer? What to Expect: Sentinel Lymph Node Biopsy for Breast Cancer When Can I Skip Axillary Dissection After Positive Nodes?

Get notified when new evidence is published on female breast upper-outer quadrant cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.

    Aleskandarany MA, Sonbul SN, Mukherjee A, Rakha EA

    Pathobiology : journal of immunopathology, molecular and cellular biology 2015; (82(3-4)):113-23 doi:10.1159/000433583.

    PMID: 26330352
  2. 2

    Peritumoral lymphatic vessel density and invasion detected with immunohistochemical marker D240 is strongly associated with distant metastasis in breast carcinoma.

    Norhisham NF, Chong CY, Safuan S

    BMC clinical pathology 2017; (17()):2 doi:10.1186/s12907-017-0041-4.

    PMID: 28203117
  3. 3

    Breast Imaging: Correlation Between Axillary Lymph Nodes Apparent Diffusion Coefficient and Pathological Lymphovascular Invasion in Patients With Invasive Breast Cancer.

    Mounir AM, Shokeir FA, Abd Elraouf GH

    European journal of breast health 2025; (21(2)):141-153 doi:10.4274/ejbh.galenos.2025.2024-10-4.

    PMID: 40079346
  4. 4

    Correlation of lymphovascular invasion with clinicopathological factors in invasive breast cancer: a meta-analysis.

    Shen SD, Zhong SZ, Wang CZ, Huang WH

    International journal of clinical and experimental medicine 2015; (8(10)):17789-95.

    PMID: 26770370
  5. 5

    The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: a systematic review and meta-analysis.

    Zhang S, Zhang D, Yi S, et al.

    Oncotarget 2017; (8(2)):2863-2873 doi:10.18632/oncotarget.13752.

    PMID: 27926511
  6. 6

    Association of Breast Cancer Subtypes and Clinicopathological Factors with Axillary Lymph Node Positivity Amongst Women with Breast Cancer in Rajasthan: An Observational Analytical Study.

    Patel P, Kumar N, Babu A, et al.

    Indian journal of surgical oncology 2024; (15(4)):768-776 doi:10.1007/s13193-024-01987-x.

    PMID: 39555353
  7. 7

    Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers.

    He KW, Sun JJ, Liu ZB, et al.

    Medicine 2017; (96(44)):e8490 doi:10.1097/MD.0000000000008490.

    PMID: 29095309
  8. 8

    Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study.

    Houvenaeghel G, Cohen M, Classe JM, et al.

    ESMO open 2021; (6(6)):100316 doi:10.1016/j.esmoop.2021.100316.

    PMID: 34864349
  9. 9

    Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis.

    Zhong YM, Tong F, Shen J

    BMC cancer 2022; (22(1)):102 doi:10.1186/s12885-022-09193-0.

    PMID: 35073848
  10. 10

    Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.

    Hamy AS, Lam GT, Laas E, et al.

    Breast cancer research and treatment 2018; (169(2)):295-304 doi:10.1007/s10549-017-4610-0.

    PMID: 29374852
  11. 11

    Updates on Lymphovascular Invasion in Breast Cancer.

    Kuhn E, Gambini D, Despini L, et al.

    Biomedicines 2023; (11(3)) doi:10.3390/biomedicines11030968.

    PMID: 36979946
  12. 12

    Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer.

    Makower D, Lin J, Xue X, Sparano JA

    NPJ breast cancer 2021; (7(1)):20 doi:10.1038/s41523-021-00231-x.

    PMID: 33649322
  13. 13

    Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes.

    Lee SJ, Go J, Ahn BS, et al.

    Frontiers in oncology 2023; (13()):1269971 doi:10.3389/fonc.2023.1269971.

    PMID: 38053656
  14. 14

    An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer.

    Nishimura R, Osako T, Okumura Y, et al.

    Oncology letters 2022; (24(2)):245 doi:10.3892/ol.2022.13366.

    PMID: 35761943
  15. 15

    The Presence of Extensive Lymphovascular Invasion is Associated With Higher Risks of Local-Regional Recurrence Compared With Usual Lymphovascular Invasion in Curatively Treated Breast Cancer Patients.

    Koleoso O, Toumbacaris N, Brogi E, et al.

    International journal of radiation oncology, biology, physics 2024; (120(3)):835-844 doi:10.1016/j.ijrobp.2024.04.073.

    PMID: 38710417
  16. 16

    Are There High-Risk Prognostic Factors for Isolated Locoregional Recurrence in Patients With Early-Stage Breast Cancer Treated With Mastectomy Without Adjuvant Radiation Therapy?

    Facondo G, Reverberi C, Prisco A, et al.

    Advances in radiation oncology 2025; (10(11)):101877 doi:10.1016/j.adro.2025.101877.

    PMID: 41142181
  17. 17

    Diagnostic concordance of reporting lymphovascular invasion in breast cancer.

    Rakha EA, Abbas A, Pinto Ahumada P, et al.

    Journal of clinical pathology 2018; (71(9)):802-805 doi:10.1136/jclinpath-2017-204981.

    PMID: 29599396

This page explains lymphovascular invasion on a breast cancer pathology report for informational purposes only and does not constitute medical advice. Your pathologist and oncology team can interpret the finding with your complete report and treatment plan.